Philochem is a Swiss subsidiary of the Philogen group, dedicated to innovating chemistry in the field of chemical pharmaceutical products and technologies. As a discovery center, Philochem focuses on developing cutting-edge solutions that have the potential to revolutionize the pharmaceutical industry. With a strong emphasis on research and development, Philochem aims to create novel and effective therapies for various diseases.

Their pipeline consists of exciting projects, including OncoFAP-Radio Conjugates, OncoFAP-Drug Conjugate, and Onco IX (PHC-102, Imaging). These innovative products and technologies hold promise in the diagnosis and treatment of different medical conditions. Philochem also actively participates in industry events and conferences, such as TIDES Europe and PEGS Europe, where their experts share their knowledge and contribute to the scientific community.

If you are passionate about chemistry and want to make a difference in the pharmaceutical field, Philochem offers opportunities for careers and collaboration through their Industrial Ph. D. Program and Partnering options.

Experience the power of innovation with Philochem and join them in pushing the boundaries of chemistry in the pursuit of better healthcare solutions